Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: Effects of short- and long-term vitamin C therapy

Citation
Gr. Ellis et al., Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: Effects of short- and long-term vitamin C therapy, J AM COL C, 36(5), 2000, pp. 1474-1482
Citations number
42
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
ISSN journal
07351097 → ACNP
Volume
36
Issue
5
Year of publication
2000
Pages
1474 - 1482
Database
ISI
SICI code
0735-1097(20001101)36:5<1474:NSACEF>2.0.ZU;2-G
Abstract
OBJECTIVES First, we sought to study the effects of short- and long-term vi tamin C therapy on oxidative stress and endothelial dysfunction in chronic heart failure (CHF), and second, we sought to investigate the role of neutr ophils as a cause of oxidative stress in CHF. BACKGROUND Oxidative stress may contribute to endothelial dysfunction in CH F. Vitamin C ameliorates endothelial dysfunction in CHF, presumably by redu cing oxidative stress, but this is unproven. METHODS We studied 55 patients with CHF (ischemic and nonischemic etiologie s) and 15 control subjects. Flow-mediated dilation (FMD) in the brachial ar tery was measured by ultrasound wall-tracking, neutrophil superoxide anion (O-2(-)) generation by lucigenin-enhanced chemiluminescence and oxidative s tress by measurement of free radicals (FRs) in venous blood using electron paramagnetic resonance (EPR) spectroscopy and plasma thiobarbituric acid re active substances (TEARS). Measurements were performed at baseline in all s ubjects. The effects of short-term (intravenous) and long-term (oral) vitam in C therapy versus placebo were tested in patients with nonischemic CHF. RESULTS At baseline, FRs were higher in patients with CHF than in control s ubjects (p < 0.01), TEARS were greater (p < 0.005), neutrophil O-2(-)-gener ating capacity was enhanced (p < 0.005) and FMD was lower (p < 0.0001). Com pared with placebo, short-term vitamin C therapy reduced FR levels (p < 0.0 5), tended to reduce TEARS and increased FMD (p < 0.05), but did not affect neutrophil O-2(-)-generating capacity. Long-term vitamin C therapy reduced FR levels (p < 0.05), reduced TEARS (p < 0.05) and improved FMD (p < 0.05) , but also reduced neutrophil O-2(-)-generating capacity (p < 0.05). Endoth elial dysfunction was not related to oxidative stress, and improvements in FMD with vitamin C therapy did not relate to reductions in oxidative stress . CONCLUSIONS Oxidative stress is increased in ischemic and nonischemic CHF, and neutrophils may be an important cause. Vitamin C reduces oxidative stre ss, increases FMD and, when given long term, decreases neutrophil O-2(-) ge neration, but the lack of a correlation between changes in endothelial func tion and oxidative stress with vitamin C implies possible additional non-an tioxidant benefits of vitamin C. (C) 2000 by the American College of Cardio logy.